Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00147901
Status:
COMPLETED
Last Update Posted:
2016-10-03
First Post:
2005-09-02
Brief Title:
Fludarabine Cyclophosphamide and Alemtuzumab in Patients With B-cell Chronic Lymphatic Leukemia B-CLL
Sponsor:
German CLL Study Group
Organization:
German CLL Study Group
Organization Data
Organization:
German CLL Study Group
Class:
OTHER
Study ID:
CLL-2L
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
German CLL Study Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| MedacSchering Onkologie | UNKNOWN |
| University of Cologne | OTHER |